Lymphokine-activated killer lymphocytes: biotherapeutics clinical trials.
West
W H
WH
Biotherapeutics, Inc., Memphis, Tennessee.
D006801:Humans; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000627:therapeutic use; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology*; D009369:Neoplasms / Q000628:therapy*
D007376:Interleukin-2